Provided by Tiger Trade Technology Pte. Ltd.

Bolt Biotherapeutics, Inc.

4.95
+0.03000.61%
Post-market: 4.950.00000.00%16:54 EST
Volume:21.97K
Turnover:112.03K
Market Cap:9.50M
PE:-0.22
High:5.20
Open:4.93
Low:4.93
Close:4.92
52wk High:10.50
52wk Low:4.41
Shares:1.92M
Float Shares:1.44M
Volume Ratio:0.69
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.2638
EPS(LYR):-33.0600
ROE:-81.97%
ROA:-32.04%
PB:0.30
PE(LYR):-0.15

Loading ...

Sarah Nemec, Senior VP Finance and PAO, Reports Acquisition of Bolt Biotherapeutics Inc. Common Shares

Reuters
·
Feb 05

ADVISORY-Alert wrongly tagged to Bolt Biotherapeutics Inc withdrawn

Reuters
·
Jan 22

Bolt Enters Gaming Through Partnership With Playfinity

THOMSON REUTERS
·
Jan 22

BRIEF-Bolt Appoints Olta Andoni As Svp Of Legal And People To Support Platform Expansion Across Checkout, Identity, And Payments

Reuters
·
Jan 15

Bolt Appoints Olta Andoni as Svp of Legal and People to Support Platform Expansion Across Checkout, Identity, and Payments

THOMSON REUTERS
·
Jan 15

Bolt Metals Upsizes Private Placement to $6 Million on Strong Demand

TIPRANKS
·
Jan 10

Jeep Parent Stellantis And Bolt Team Up To Launch Robotaxis Across Europe

Benzinga_recent_news
·
Dec 09, 2025

Bolt Metals Secures $430,000 in First Tranche of LIFE Offering

TIPRANKS
·
Nov 20, 2025

Bolt Biotherapeutics posts Q3 revenue of $2.2 million and R&D expenses of $6.5 million

Reuters
·
Nov 13, 2025

Bolt Biotherapeutics Inc expected to post a loss of $5.79 a share - Earnings Preview

Reuters
·
Nov 07, 2025

Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment

TIPRANKS
·
Oct 28, 2025

Senior VP Sarah Nemec Acquires Common Shares of Bolt Biotherapeutics Inc

Reuters
·
Oct 25, 2025

William P. Quinn, President, CEO and CFO, acquires common shares of Bolt Biotherapeutics Inc

Reuters
·
Oct 25, 2025

Bolt Metals Corrects Private Placement Amount in Recent Announcement

TIPRANKS
·
Oct 24, 2025

Bolt Metals Advances Northwind Gold Project Amidst Soaring Gold Prices

TIPRANKS
·
Oct 24, 2025

Bolt Biotherapeutics Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Oct 20, 2025

Bolt Biotherapeutics Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $7

THOMSON REUTERS
·
Oct 20, 2025

Bolt Metals Announces Share Consolidation and Strategic Portfolio Update

TIPRANKS
·
Oct 16, 2025

Bolt Metals Closes $600,000 Private Placement to Bolster Working Capital

TIPRANKS
·
Oct 11, 2025

Bolt Biotherapeutics Announces Major Restructuring Plan

TIPRANKS
·
Oct 03, 2025